AES - DRS - Synexus Clinical Research US, Inc. - Chicago

Chicago, Illinois 60654-4855

1 studies enrolling now · 4 studies all time

What they study most

Influenza, Respiratory Syncytial Virus, SARS-CoV-2, Type II Diabetes Mellitus

Studies at this site

• A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus — Recruiting now
• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed
• A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age — Completed
• Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study — Completed